Journal Article Summary
The article investigates the synthesis and antifungal properties of six new imidazoline derivatives, focusing particularly on one compound, N-cyclohexyl-2-imino-3-(4-nitrophenyl)imidazolidine-1-carboxamide (referred to as compound 4f). This research is significant due to the increasing prevalence of fungal infections, particularly those caused by Candida species, which can be life-threatening, especially in immunocompromised individuals. The study aims to contribute to the search for more effective antifungal agents, as current treatments often have limitations such as toxicity and resistance.
In the study, the researchers synthesized the imidazoline derivatives and tested their antifungal activity against various strains of Candida, including clinical isolates. Among the compounds, 4f demonstrated moderate antifungal activity, with its effectiveness varying depending on the strain tested. The minimum inhibitory concentration (MIC) values indicated that while 4f was less potent than the established antifungal clotrimazole, it still showed promise for further development. The structure of compound 4f was confirmed through X-ray crystallography, and molecular modeling suggested that its mechanism of action may be similar to that of fluconazole, a commonly used antifungal medication.
Despite the promising results, the study has limitations, including the need for further optimization of compound 4f to enhance its antifungal activity. Additionally, the research primarily focused on laboratory conditions, which may not fully replicate the complexities of human infections. Patients and caregivers should consult healthcare professionals regarding fungal infections and treatment options, especially considering the potential for drug interactions and side effects associated with existing antifungal therapies. This discussion is crucial for understanding the best course of action for managing fungal infections effectively.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Wróbel Tomasz M., Kosikowska Urszula, Kaczor Agnieszka A., Andrzejczuk Sylwia, Karczmarzyk Zbigniew, Wysocki Waldemar, Urbańczyk-Lipkowska Zofia, Morawiak Maja, et al.. Synthesis, Structural Studies and Molecular Modelling of a Novel Imidazoline Derivative with Antifungal Activity. Molecules 2015. DOI: 10.3390/molecules200814761. PMID: 26287137. PMCID: PMC6332182.
Featured Pill Pals Product
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) --- Generic for Lotrimin AF Pack of 5 --- Major / Rugby --- Over The Counter
Clotrimazole 1 Percent (1%) Cream 28g (1 oz) — Generic for Lotrimin AF Pack of 5 — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
